BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20554020)

  • 1. SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats.
    Nnamani PO; Attama AA; Ibezim EC; Adikwu MU
    Eur J Pharm Biopharm; 2010 Sep; 76(1):68-74. PubMed ID: 20554020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of nanoparticles of glibenclamide by solvent displacement method.
    Dora CP; Singh SK; Kumar S; Datusalia AK; Deep A
    Acta Pol Pharm; 2010; 67(3):283-90. PubMed ID: 20524431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the properties of Gongronema latifolium in phospholipon 90H based solid lipid microparticles (SLMs): an antidiabetic study.
    Chime SA; Onyishi IV; Ugwoke PU; Attama AA
    J Diet Suppl; 2014 Mar; 11(1):7-18. PubMed ID: 24409977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
    Jain S; Saraf S
    J Diabetes; 2009 Mar; 1(1):29-35. PubMed ID: 20923517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
    Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
    J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of an oily-based system for oral delivery of insulin.
    Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
    Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid microparticles as a sustained release system for pulmonary drug delivery.
    Jaspart S; Bertholet P; Piel G; Dogné JM; Delattre L; Evrard B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):47-56. PubMed ID: 16962749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo.
    Umeyor EC; Kenechukwu FC; Ogbonna JD; Chime SA; Attama A
    J Microencapsul; 2012; 29(3):296-307. PubMed ID: 22283701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid micro-dispersions (SLMs) based on PEGylated solidified reverse micellar solutions (SRMS): a novel carrier system for gentamicin.
    Kenechukwu FC; Momoh MA; Nnamani PO; Attama AA
    Drug Deliv; 2015; 22(6):710-22. PubMed ID: 24724962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
    Momoh MA; Kenechukwu FC; Attama AA
    Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient pH sensitive oral insulin delivery system enhanced by deoxycholic acid.
    Zhao L; Ding J; He P; Xiao C; Tang Z; Zhuang X; Chen X
    J Control Release; 2011 Nov; 152 Suppl 1():e184-6. PubMed ID: 22195840
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
    Dhana Lekshmi UM; Poovi G; Kishore N; Reddy PN
    Int J Pharm; 2010 Aug; 396(1-2):194-203. PubMed ID: 20600729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
    Salmaso S; Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2009 Feb; 98(2):640-50. PubMed ID: 18484622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.